NPPB and COVID-19: Of note, we observed that NT-proBNP levels at admission were increased in critically ill COVID-19 patients or in those who died compared to non-severe patients; an effect that was consistent in both subgroups of patients (severe vs. non-severe; non-survivors vs. survivors).